|
Volumn 5, Issue 1 SUPPL., 1999, Pages
|
Health economics and sexual dysfunction
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOMORPHINE;
ARGININE;
PHENTOLAMINE;
SILDENAFIL;
CLINICAL RESEARCH;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
ERECTILE DYSFUNCTION;
FIBROSIS;
HEALTH CARE COST;
HEALTH ECONOMICS;
HUMAN;
INJECTION PAIN;
MALE;
MANAGED CARE;
PATIENT COUNSELING;
PRIORITY JOURNAL;
PUMP;
QUALITY OF LIFE;
SEX THERAPY;
VACUUM;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
HUMANS;
IMPOTENCE;
INSURANCE COVERAGE;
LIFE STYLE;
MALE;
MANAGED CARE PROGRAMS;
MEDICAL SAVINGS ACCOUNTS;
PIPERAZINES;
RESEARCH SUPPORT;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 0032890571
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (3)
|